Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Bril

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|October 3, 2003
Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECAHelen L Maddock, Neil M Gardner, Nassirah Khandoudi, et al.
Diabetes|April 30, 2002
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injuryNassirah Khandoudi, Philippe Delerive, Isabelle Berrebi-Bertrand, et al.
Nature Reviews. Drug Discovery|April 2, 2014
Integrative knowledge management to enhance pharmaceutical R&DMaria Marti-Solano, Ewan Birney, Antoine Bril, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Late neointimal tissue growth behind the stent after intravascular gamma-radiationDavid Busseuil, Marianne Zeller, Yves Cottin, et al.
Drug Discovery Today|February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspectiveInkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
The Journal of Biological Chemistry|August 1, 2002
Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsivenessIsabelle Lefrere, Pierre De Coppet, Jean-Claude Camelin, et al.
American Journal of Physiology. Cell Physiology|February 11, 2012
RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertensionChrystelle Cario-Toumaniantz, David Ferland-McCollough, Gilliane Chadeuf, et al.
Nature Medicine|January 26, 2010
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressureChristophe Guilluy, Jérémy Brégeon, Gilles Toumaniantz, et al.
Journal of Cell Science|February 28, 2002
Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomereMichel Souchet, Elodie Portales-Casamar, David Mazurais, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 29, 2004
Beneficial effects of direct call to emergency medical services in acute myocardial infarctionBruno Cabrita, Florence Bouyer-Dalloz, Isabelle L'Huillier, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|October 3, 2003
Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECAHelen L Maddock, Neil M Gardner, Nassirah Khandoudi, et al.
Diabetes|April 30, 2002
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injuryNassirah Khandoudi, Philippe Delerive, Isabelle Berrebi-Bertrand, et al.
Nature Reviews. Drug Discovery|April 2, 2014
Integrative knowledge management to enhance pharmaceutical R&DMaria Marti-Solano, Ewan Birney, Antoine Bril, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Late neointimal tissue growth behind the stent after intravascular gamma-radiationDavid Busseuil, Marianne Zeller, Yves Cottin, et al.
Drug Discovery Today|February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspectiveInkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
The Journal of Biological Chemistry|August 1, 2002
Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsivenessIsabelle Lefrere, Pierre De Coppet, Jean-Claude Camelin, et al.
American Journal of Physiology. Cell Physiology|February 11, 2012
RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertensionChrystelle Cario-Toumaniantz, David Ferland-McCollough, Gilliane Chadeuf, et al.
Nature Medicine|January 26, 2010
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressureChristophe Guilluy, Jérémy Brégeon, Gilles Toumaniantz, et al.
Journal of Cell Science|February 28, 2002
Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomereMichel Souchet, Elodie Portales-Casamar, David Mazurais, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 29, 2004
Beneficial effects of direct call to emergency medical services in acute myocardial infarctionBruno Cabrita, Florence Bouyer-Dalloz, Isabelle L'Huillier, et al.
Pageof 3